http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008533990-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7088 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01K67-027 |
| filingDate | 2006-03-22^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2008-08-28^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2008533990-A |
| titleOfInvention | Influenza treatment |
| abstract | The present invention provides a composition comprising an RNAi-inducing entity targeted to an influenza virus transcript and any of a variety of delivery factors. The invention further encompasses methods of using the compositions to inhibit the biological activity of influenza virus and / or to treat or prevent influenza. The present invention relates to target subsequences that are preferably conserved against RNAi over multiple influenza virus A strains isolated from human and / or avian hosts and RNAi targeted to such preferably conserved target portions. Provides an inductive entity. The present invention provides a variety of nucleic acids comprising sequences that are identical or complementary to at least a portion of one or more of these preferably conserved target subsequences. The present invention further provides methods and compositions for delivering an RNAi-inducing agent to an organ or tissue (eg, lung) of a mammalian subject. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114206906-A |
| priorityDate | 2005-03-22^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Showing number of triples: 1 to 918 of 918.